MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
The investigators hypothesize that this single-cell analysis can be used to evaluate prostate needle-core biopsies prospectively even in non-homogenous samples by providing profiles of proteomic and phenotypic signatures. These profiles will in turn enable better predictions of the malignant progression of prostate cancers in the settings of current clinical practice.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• Only subjects that have scheduled Artemis prostate biopsy with defined regions of interest will be included in this study
Locations
United States
Connecticut
Yale University
RECRUITING
New Haven
Contact Information
Primary
Preston Sprenkle, MD
Preston.Sprenkle@yale.edu
Time Frame
Start Date: 2013-07
Estimated Completion Date: 2025-10
Participants
Target number of participants: 600
Treatments
Patient Scheduled for Prostate Fusion Biopsies
For subjects with scheduled fusion biopsies, we propose a research plan to acquire additional biopsy cores for research purposes without impacting clinical protocol. After acquiring clinically-necessary biopsies, we propose taking an additional research biopsy to establish a matched-pair of clinical and research samples.
Related Therapeutic Areas
Sponsors
Leads: Yale University